Introduction {#s0005}
============

Vitamin D was originally discovered by Edward Mellanby in 1919 ([@bb0005], [@bb0010]). Over the past years, studies indicated that vitamin D not only has an important function in bones, but it also significantly affects cell proliferation and differentiation. In cancer cells, the active metabolite of vitamin D, 1,25-dihydroxycholecalciferol (1,25(OH)2D3) can suppress cell proliferation ([@bb0015]). Many studies suggested that serum concentrations of vitamin D metabolites have been inversely associated with risk for breast cancer development ([@bb0025], [@bb0020]).

The effects of vitamin D for the most part are correlated with nuclear vitamin D receptor (VDR). It has been well established that the active hormone 1,25(OH)2D3 can induce a cascade of gene regulation and signaling molecules by binding to VDR ([@bb0030]). However a series of polymorphisms in VDR gene have been reported. They include Bsm1, Apa1, Taq1 restriction sites, variable PolyA length and Fok1 restriction site ([@bb0035]). Of these polymorphic sites Bsm1 and Apa1 are substitutions on intron 8 whereas Taq1 brings about substitution of cytosine to thymine on exon 9. The Fork1 restriction enzyme identifies a polymorphic site in exon 2 at the 50 end of the VDR gene.

Over the years, most of the molecular epidemiological studies were performed on Caucasian women to assess the associations of different VDR polymorphisms with breast cancer risk ([@bb0045], [@bb0125], [@bb0075], [@bb0050], [@bb0055], [@bb0120], [@bb0110], [@bb0085], [@bb0135], [@bb0060], [@bb0080], [@bb0090], [@bb0095], [@bb0115], [@bb0065], [@bb0130], [@bb0100], [@bb0040], [@bb0105], [@bb0070], [@bb0140]). However, the results are inconsistent, which might be caused by the limitation of individual studies. Therefore we performed this meta-analysis which combines data from all published literatures to get a more precise evaluation of the association in Caucasian women.

Methods {#s0010}
=======

Search strategy {#s0025}
---------------

In this meta-analysis, a comprehensive literature research of the US National Library of Medicine\'s PubMed database, ISI Web of Knowledge, Medline, Embase and Google Scholar Search (update to December, 2012) was conducted using the search terms including "breast cancer", "vitamin D receptor (VDR)", "polymorphism", "Fok1", "Apa1", "Bsm1", "Taq1", and the combined phrases in order to obtain all genetic studies on the relationship of the polymorphisms with breast cancer in Caucasian women. We also used a hand search of references of original studies or reviewed articles on this topic to identify additional studies.

Data extraction {#s0030}
---------------

Data extraction was carried out independently by two investigators. For each eligible study, the following information was recorded: the first author\'s name, the year of publication, country of origin, genotyping methods, racial descent of the study population, number of cases and controls with different genotypes.

Statistical analysis {#s0035}
--------------------

The strength of relationship between the four polymorphisms of VDR and breast cancer was assessed by using Crude OR with 95% CI. We examined the association using homozygote comparison, heterozygote comparison, dominant genetic model and recessive genetic model of the four polymorphisms. Between-study heterogeneity was evaluated by the χ2-based Q-test and the heterogeneity was considered significant when P \< 0.05 ([@bb0145]). Fixed-effects model (the Mantel--Haenszel method) was used to pool the data when the P-value of Q-test ≥ 0.05, otherwise, random-effects model (the DerSimonian and Laird method) was selected ([@bb0150], [@bb0155]). These two models provided similar results when between-study heterogeneity was absent. Both funnel plot and Egger\'s test were used to assess the publication bias (P \< 0.05 was considered representative of statistical significance) ([@bb0160]). All statistical analyses were performed using STATA11.0 software.

Results {#s0015}
=======

Eligible studies {#s0040}
----------------

The main characteristics of all the 21 studies are shown in [Table 1](#t0005){ref-type="table"}. Genotype distribution of the studied polymorphisms among cancer cases and controls of the studies is shown in the supplementary material. The genotyping method contains the classic polymerase chain reaction--restriction fragment length polymorphism (PCR--RFLP) assay, DNA sequencing, Affymetrix, TaqMan, MassARRAY system and Allele-specific PCR. All studies were case--control and Caucasian descent. Hospital based controls were carried out in ten studies, while population based controls were carried out in 11 studies. The distribution of genotypes in the controls was all in agreement with Hardy--Weinberg equilibrium except for five studies ([@bb0075], [@bb0080], [@bb0040], [@bb0070], [@bb0140]).

Meta-analysis {#s0045}
-------------

The main results of this meta-analysis and the heterogeneity tests were shown in [Table 2](#t0010){ref-type="table"}. Overall, we did not find any association of all the studied polymorphisms with breast cancer risk in Caucasian women.

For Fok1, no association with breast cancer risk was found in all the models (ff vs. FF: OR = 1.05, 95% CI = 0.95--1.22, P = 0.32 for heterogeneity; ff vs. Ff: OR = 1.05, 95% CI = 0.94--1.17, P = 0.40; ff vs. Ff + FF: OR = 1.07, 95% CI = 0.95--1.14, P = 0.37 and ff + Ff vs. FF: OR = 1.04, 95% CI = 0.99--1.09, P = 0.23).

For Bsm1, Apa1 and Taq1, we also did not find any significant association in the homozygote comparison, heterozygote comparison, recessive and dominant models respectively.

Publication bias {#s0050}
----------------

Both Begg\'s funnel plot and Egger\'s test were performed to assess the publication bias of the literature. The shape of the funnel plots did not reveal any evidence of obvious asymmetry in the overall meta-analysis ([Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}, [Fig. 3](#f0015){ref-type="fig"}, [Fig. 4](#f0020){ref-type="fig"}, [Fig. 5](#f0025){ref-type="fig"}). Then, Egger\'s test was used to provide statistical evidence of funnel plot symmetry. The results still did not present any obvious evidence of publication bias (data not shown).

Discussion {#s0020}
==========

This meta-analysis encompassing 21 studies involving 38,151 cases and 47,546 controls was conducted to investigate the potential association between four polymorphisms of VDR and breast cancer risk in Caucasian women. Overall, we did not find any association of all the studied four SNPs with breast cancer risk in Caucasian women.

Up to now, Fok1 is the most controversial SNP concerning its relationship with breast cancer risk, VDR FF allele in combination with long-Poly A was reported to be a risk factor in the UK ([@bb0060]), whereas in another report Chen ([@bb0170]) found VDR ff to be a risk factor in the Nurses\' Health study in the USA. In 2009, the meta-analysis conducted by Tang et al. indicated a positive association between VDR ff and augmented risk for breast cancer in European women ([@bb0175]). Yet other reports did not find any correlation between Fok1 polymorphism and breast cancer incidence. Most recently, Shahbazi et al. found no statistically significant association between Fok1 genotypes and breast cancer risk in Iranian breast cancer patients ([@bb0180]). Our analysis involving 13,152 cases and 17,443 controls confirmed that Fok1 was not overall significantly associated with breast cancer risk in Caucasian women.

Compared to Fok1, the Bsm1 exhibits strong linkage disequilibrium with Apa1 and Taq1, located at the 30 untranslated region (30 UTR) of the VDR gene. This haplotype may affect mRNA stability and processing as well as regulation of VDR transcription and translation ([@bb0135], [@bb0140]). Among all the studies, only four studies which were performed on Caucasian women reported an increased risk of breast cancer with the Bsm1 bb genotype ([@bb0075], [@bb0115], [@bb0190], [@bb0185]). Curran et al. claimed that allele frequencies of the Apa1 polymorphism showed a significant association with breast cancer risk, other studies found no association ([@bb0055]). Comparing t allele carriers with non-carriers, Abbas et al. conducted one study suggesting that the Taq1 polymorphism was associated with a significantly increased breast cancer risk in estrogen receptor positive patients ([@bb0045]). Other studies did not find significant overall association in Caucasian women. Concerning the strong linkage disequilibrium of the three polymorphisms, combinations of the three variants may be more discriminating as risk factors than a single one.

As in all research, our study has limitations. Firstly, the controls were not uniformly defined. Secondly, since there is a lack of detailed individual information on genotypes of Bsm1, Apa1 and Taq1, we could not perform the pooled analysis of linkage disequilibrium and the combined genotypes of these three SNPs. Thirdly, due to the original data of the eligible studies are unavailable. We did not perform the analysis adjusted for some covariates such as: age, dietary vitamin D, sun exposure, intake and steroid hormone receptor status.

In conclusion, this analysis suggested that the four polymorphisms (Fok1, Bsm1, Apa1 and Taq1) of VDR may be not associated with breast cancer risk in Caucasian women.

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
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###### 

The main characteristics of all the studies in this meta-analysis.

  Author             Year   Country     Ethnicity   Source of control   Matching criteria          Case/control   Genotyping methods     Studied polymorphism     HWE
  ------------------ ------ ----------- ----------- ------------------- -------------------------- -------------- ---------------------- ------------------------ -----
  Curran             1999   Australia   Caucasian   Population          Age                        135/110        PCR--RFLP              Fok1, Apa1, Taq1         Y
  Dunning1           1999   UK          Caucasian   Hospital            Age, residential area      211/268        PCR--RFLP              Taq1                     Y
  Dunning2           1999   UK          Caucasian   Hospital            Age, residential area      740/359        PCR--RFLP              Taq1                     Y
  Lundin             1999   Sweden      Caucasian   Population          Age                        111/130        PCR--RFLP              Taq1                     Y
  Ingles             2000   America     Caucasian   Hospital            Residential area           143/300        PCR--RFLP              Bsm1                     Y
  Guy                2004   UK          Caucasian   Hospital            Age                        398/427        PCR--RFLP              Fok1, Bsm1               Y
  Sillanpaa          2004   Finnish     Caucasian   Hospital            Age, residential area      483/482        PCR--RFLP              Apa1, Taq1               Y
  Hefler             2004   Germany     Caucasian   Population          Age                        1699/1963      Microarray system      Bsm1                     N
  Chen               2005   Turkey      Caucasian   Hospital            Age and residential area   1234/1676      TaqMan                 Fok1                     Y
  Lowe               2005   UK          Caucasian   Hospital            Age, residential area      179/179        PCR--RFLP              Bsm1                     Y
  McKay              2008   America     Caucasian   Population          Age, hormone status        4657/6578      TaqMan                 Fok1, Bsm1               Y
  Dana E. Rollison   2011   America     Caucasian   Population          Age, regional area         2318/2512      PCR                    Bsm1, Fokl               Y
  Ruggiero           1998   Italy       European    Population          Age, residential area      88/167         PCR--RFLP              Bsm1                     N
  Engel              2012   America     Caucasian   Population          Race, regional area        806/1650       MassARRAY system       Apa1, Fokl, Taq1         Y
  McCullough         2007   America     Caucasian   Hospital            Age, residential area      500/500        TaqMan                 Fok1, Apa1, Bsm1, Taq1   Y
  Trabert            2007   America     Caucasian   Hospital            Age, residential area      1136/965       PCR--RFLP              Bsm1                     Y
  Abbas              2008   Germany     Caucasian   Population          Age                        1408/2612      PCR--RFLP              Fok1, Taq1               Y
  Buyru              2003   Turkey      Caucasian   Population          NA                         27/78          PCR--RFLP              Bsm1, Taq1               N
  Sinotte1           2008   Canada      Caucasian   Population          Regional match             225/463        Allele--specific PCR   Fok, Bsm1                Y
  Scott              2008   Poland      Caucasian   Hospital            Age, regional match        960/800        RT-PCR                 Apa1, Fokl               Y
  Anderson           2011   Canada      Caucasian   Population          Age                        6201/6509      MassARRAY system       Apa1, Fokl, Bsm1, Taq1   Y
  Dalessandri,       2011   America     Caucasian   Population          Age, ethnicity             164/174        Allele-specific PCT    Apa1                     Y
  Sinotte2           2008   Canada      Caucasian   Population          Regional match             622/974        Allele-specific PCR    Fok1, Bsm1               Y

###### 

The main results of this meta-analysis.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Polymorphisms   ORs and 95% CI                                      P[a](#tf0005){ref-type="table-fn"}   ORs and 95% CI     P[a](#tf0005){ref-type="table-fn"}   ORs and 95% CI                                      P[a](#tf0005){ref-type="table-fn"}   ORs and 95% CI                                      P
  --------------- --------------------------------------------------- ------------------------------------ ------------------ ------------------------------------ --------------------------------------------------- ------------------------------------ --------------------------------------------------- ------
  ForkI           ff vs. FF\                                          0.32                                 ff vs. Ff\         0.40                                 ff vs. Ff + FF\                                     0.37                                 ff + Ff vs. FF\                                     0.23
                  1.05(0.95--1.22)                                                                         1.05(0.94--1.17)                                        1.07(0.95--1.14)                                                                         1.04(0.99--1.09)                                    

                                                                                                                                                                                                                                                                                                                

  ApaI            aa vs. AA\                                          0.34                                 aa vs. Aa\         0.11                                 aa vs. Aa + AA\                                     0.25                                 Aa + aa vs. AA\                                     0.01
                  1.00(0.87--1.18)                                                                         0.87(0.85--1.10)                                        0.88(0.86--1.12)                                                                         1.08(0.80--1.30)[b](#tf0010){ref-type="table-fn"}   

                                                                                                                                                                                                                                                                                                                

  BsmI            bb vs. BB\                                          0.01                                 bb vs. Bb\         0.06                                 bb + Bb vs. BB\                                     0.04                                 bb vs. BB + Bb\                                     0.02
                  1.00(0.90--1.11)[b](#tf0010){ref-type="table-fn"}                                        1.02(0.9--1.22)                                         1.01(0.95--1.03)[b](#tf0010){ref-type="table-fn"}                                        1.01(0.91--1.13)[b](#tf0010){ref-type="table-fn"}   

                                                                                                                                                                                                                                                                                                                

  TaqI            tt vs. TT\                                          0.12                                 tt vs. Tt\         0.21                                 tt vs. TT + Tt\                                     0.06                                 tt + Tt vs. TT\                                     0.41
                  1.05(0.95--1.16)                                                                         1.00(0.91--1.10)                                        1.02(0.93--1.12)                                                                         1.04(0.97--1.11)                                    
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: CI, confidence interval; OR, odds ratio.

P-value of Q-test for heterogeneity test.

Random model was used.
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